Eudaimonia Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.05M Sell
6,666
-433
-6% -$68.9K 0.25% 90
2023
Q4
$1.11M Sell
7,099
-2,797
-28% -$429K 0.29% 76
2023
Q3
$1.54M Sell
9,896
-250
-2% -$41.3K 0.37% 60
2023
Q2
$1.68M Buy
10,146
+165
+2% +$26.6K 0.38% 63
2023
Q1
$1.55M Sell
9,981
-1,624
-14% -$262K 0.37% 61
2022
Q4
$2.05M Sell
11,605
-2,971
-20% -$513K 0.5% 48
2022
Q3
$2.38M Sell
14,576
-17,252
-54% -$2.92M 0.62% 37
2022
Q2
$5.65M Buy
31,828
+2,996
+10% +$534K 1.04% 11
2022
Q1
$5.11M Buy
+28,832
New +$4.91M 0.87% 18
2021
Q3
$4.71M Buy
29,135
+14
+0% +$2.39K 0.85% 21
2021
Q2
$4.8M Buy
29,121
+2,012
+7% +$333K 0.9% 19
2021
Q1
$4.46M Buy
27,109
+326
+1% +$52.8K 0.92% 14
2020
Q4
$4.21M Sell
26,783
-111
-0.4% -$16.4K 0.95% 14
2020
Q3
$4M Sell
26,894
-667
-2% -$98.7K 1.03% 13
2020
Q2
$3.88M Buy
27,561
+224
+0.8% +$32.6K 1.47% 6
2020
Q1
$3.58M Buy
27,337
+1,059
+4% +$150K 1.57% 7
2019
Q4
$3.83M Buy
+26,278
New +$3.56M 1.52% 6

Other funds holding JNJ

Eudaimonia Partners's JNJ Position: Q1 2024 in Review

Eudaimonia Partners reduced its Johnson & Johnson (JNJ) stake by 6.1% in Q1 2024, selling an estimated $68.9K and leaving 6,666 shares worth $1.05M. The position accounts for 0.25% of the portfolio, ranked #90.

Eudaimonia Partners first reported a position in JNJ in Q4 2019 and has held it in 17 quarters since. The position peaked at $5.65M in Q2 2022. 3,848 funds tracked by Wall St. Rank hold JNJ as of Q1 2024.

  • Eudaimonia Partners held 6,666 shares of Johnson & Johnson worth $1.05M as of Q1 2024.
  • Eudaimonia Partners sold 433 Johnson & Johnson shares in Q1 2024, an estimated $68.9K.
  • Johnson & Johnson made up 0.25% of Eudaimonia Partners's portfolio in Q1 2024, its #90 holding.
  • Eudaimonia Partners first reported a position in Johnson & Johnson in Q4 2019 and has held it in 17 quarters since.
  • Eudaimonia Partners's Johnson & Johnson position peaked at $5.65M in Q2 2022.
  • 3,848 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2024.

Based on Eudaimonia Partners's 13F filing for Q1 2024, filed 25 Apr 2024.